CoreAge Rx vs OnlyRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and OnlyRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 62 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make OnlyRx a bad call — it's best for readers comparing injection and oral offers who verify the actual prescription, full payment and independent clinical arrangement first. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | OnlyRx |
|---|---|---|
| Brief Score | 94/100 (A) | 62/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Injection $179 / tablet $249 starting amounts Exact preparation, selected dose and supplied period unconfirmed; do not assume these are monthly renewal prices. Named brand referrals exclude medication cost, paid separately to a chosen pharmacy. Consultation fees become nonrefundable once the patient has received the consultation. Full price detailsSemaglutide injections and ODT advertised; exact preparation and complete current quote unknown; injection starts at $179 and oral tablet at $249 without an established public supplied period |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Injection $249 / tablet $279 starting amounts Exact preparation and supply period unconfirmed. Advertised consultation, prescription processing and shipping do not establish every selected-plan cost. Homepage all-state claim differs from limited-state terms. Confirm clinical practice, pharmacy, recurring charges and order-cancellation deadline. Full price detailsTirzepatide injections and ODT advertised; exact preparation and complete current quote unknown; injection starts at $249 and oral tablet at $279 without an established public supplied period |
| Coverage | US only; restrictions by state, confirmed at intake | Homepage advertises all 50 states; terms restrict service to available states and direct readers to support for the current list |
| Brand-name access | Not confirmed | Providers may alternatively prescribe named brands; patients fill and pay a chosen pharmacy separately, and the consultation/referral fee excludes branded medication. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
OnlyRx: Injection/tablet starting amounts lack a complete preparation and supply quote. Named brand referrals require separate pharmacy payment; verify patient-state eligibility and consultation refund terms.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.